This topical cream formulation combines Dextromethorphan HBr, Diclofenac Na, and Piroxicam to provide targeted relief for pain and inflammation associated with conditions such as arthritis, muscle sprains, and joint pain. Each gram of cream contains 40 mg of Dextromethorphan HBr, 80 mg of Diclofenac Na, and 40 mg of Piroxicam, offering a potent combination of analgesic and anti-inflammatory effects.
Dispensed in a semisolid form with a convenient pump mechanism, this preparation ensures controlled application and absorption of active ingredients directly through the skin, allowing for localized treatment of affected areas.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This topical cream formulation contains Dextromethorphan HBr, Diclofenac Na, and Piroxicam, each of which has the potential to interact with other medications, although the risk is generally lower with topical application compared to systemic administration. However, it is crucial for both patients and prescribers to be aware of potential interactions, especially if the patient is using other medications concurrently.
Dextromethorphan HBr, primarily known as a cough suppressant, can interact with medications that affect serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs). These interactions can increase the risk of serotonin syndrome, a potentially life-threatening condition. Although the risk is reduced with topical application, caution is advised if the patient is taking any serotonergic drugs.
Diclofenac Na is a nonsteroidal anti-inflammatory drug (NSAID) that can interact with other NSAIDs, anticoagulants, and antiplatelet agents, potentially increasing the risk of bleeding. It may also interact with antihypertensive medications, reducing their efficacy. Patients using oral NSAIDs or anticoagulants should be monitored closely for signs of bleeding or gastrointestinal issues, even with topical use. Additionally, patients with renal impairment should use this formulation cautiously, as NSAIDs can affect renal function.
Piroxicam, another NSAID in this formulation, shares similar interaction profiles with Diclofenac Na. It can potentiate the effects of anticoagulants and increase the risk of gastrointestinal bleeding when used with other NSAIDs or corticosteroids. Patients should be advised to avoid using other topical or systemic NSAIDs concurrently unless specifically directed by a healthcare provider.
While the topical application of this cream reduces systemic absorption and the likelihood of interactions, it is still important to consider the cumulative effects of these active ingredients, especially in patients with pre-existing conditions or those taking multiple medications. Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and supplements, to ensure safe use of this formulation.
If you have any questions or concerns about potential drug interactions with this topical cream, please reach out to us for further guidance and support.
This topical cream formulation combines three active pharmaceutical ingredients: Dextromethorphan HBr, Diclofenac Na, and Piroxicam, each contributing to the treatment of pain and inflammation through distinct mechanisms of action. The semisolid preparation is dispensed via a pump mechanism, ensuring a convenient and controlled application directly onto the skin, which facilitates localized treatment and absorption of the active ingredients.
Dextromethorphan HBr is primarily known as a cough suppressant, but it also exhibits properties that can modulate pain. It acts on the central nervous system by inhibiting the N-methyl-D-aspartate (NMDA) receptor, which plays a role in pain transmission and perception. By blocking these receptors, Dextromethorphan can help reduce the sensation of pain, making it a valuable component in managing localized pain conditions when applied topically.
Diclofenac Na is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes are involved in the synthesis of prostaglandins, which are lipid compounds that contribute to inflammation, pain, and fever. By reducing the production of prostaglandins, Diclofenac effectively decreases inflammation and alleviates pain in the affected area. Its topical application allows for targeted action, minimizing systemic exposure and potential side effects associated with oral NSAIDs.
Piroxicam, another NSAID included in this formulation, also targets the COX enzymes to reduce the synthesis of prostaglandins. When applied topically, Piroxicam penetrates the skin to exert its effects directly at the site of inflammation, enhancing its efficacy in treating localized pain and swelling.
The combination of these three active ingredients in a topical cream allows for a multifaceted approach to pain management. The formulation is designed to provide relief from pain and inflammation associated with various conditions, such as arthritis, musculoskeletal injuries, and localized neuropathic pain. The pump mechanism ensures precise dosing and easy application, making it suitable for patients who require consistent and controlled treatment.
For prescribers, this formulation offers a versatile option for patients who may benefit from a topical approach to pain management, particularly those who are unable to tolerate oral medications or who require additional localized treatment. The synergistic effects of Dextromethorphan, Diclofenac, and Piroxicam provide comprehensive relief, addressing both the sensory and inflammatory components of pain.
If you have any questions or need further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have.
This compounded topical cream is designed for localized treatment or absorption of active ingredients to provide relief from pain and inflammation. It combines Dextromethorphan HBr, Diclofenac Na, and Piroxicam to target specific areas on the skin.
The cream should be applied using the pump mechanism for a controlled and convenient application. Apply a small amount to the affected area and gently rub it in until fully absorbed. Follow your healthcare provider's instructions regarding the frequency and amount of application.
No, you should not apply this cream to broken or damaged skin. It is intended for use on intact skin only. If you have any concerns about your skin condition, consult your healthcare provider before use.
Some users may experience mild skin irritation, redness, or itching at the application site. If you experience severe reactions or if the irritation persists, discontinue use and consult your healthcare provider.
Before using this cream with other medications, especially other topical treatments, consult your healthcare provider to avoid potential interactions. They can provide guidance based on your specific health needs.
Store the cream at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Ensure the pump mechanism is securely closed when not in use.
This cream is generally intended for adult use. If you are considering using it for a child or adolescent, consult a healthcare provider to ensure it is appropriate and safe for their use.
The time it takes to feel the effects can vary depending on the individual and the severity of the condition being treated. Some users may experience relief within a few hours, while others may require several applications over a few days.
If you are pregnant or breastfeeding, consult your healthcare provider before using this cream. They can provide advice based on your specific circumstances and health needs.
If the cream is accidentally ingested, seek medical attention immediately. Provide the healthcare professional with information about the product and the amount ingested for appropriate guidance and treatment.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)